Cargando…

Long-Term Outcome of the First Completely Leadless Cardiac Resynchronization Therapy in the United States

Completely leadless cardiac resynchronization therapy is feasible with the combination of Micra AV pacemaker (Medtronic Inc) and WiSE-CRT (EBR Inc) systems. Several reports have highlighted this combination in Europe. This case report presents a 1- year follow-up the first reported concomitant use o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehlhorn, Donald, Patel, Sankalp, Verghese, Dhiran, Azad, Hashem, Sharma, Dinesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589444/
https://www.ncbi.nlm.nih.gov/pubmed/37869212
http://dx.doi.org/10.1016/j.jaccas.2023.102020
_version_ 1785123793079894016
author Mehlhorn, Donald
Patel, Sankalp
Verghese, Dhiran
Azad, Hashem
Sharma, Dinesh
author_facet Mehlhorn, Donald
Patel, Sankalp
Verghese, Dhiran
Azad, Hashem
Sharma, Dinesh
author_sort Mehlhorn, Donald
collection PubMed
description Completely leadless cardiac resynchronization therapy is feasible with the combination of Micra AV pacemaker (Medtronic Inc) and WiSE-CRT (EBR Inc) systems. Several reports have highlighted this combination in Europe. This case report presents a 1- year follow-up the first reported concomitant use of the leadless systems in the United States. (Level of Difficulty: Advanced.)
format Online
Article
Text
id pubmed-10589444
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105894442023-10-22 Long-Term Outcome of the First Completely Leadless Cardiac Resynchronization Therapy in the United States Mehlhorn, Donald Patel, Sankalp Verghese, Dhiran Azad, Hashem Sharma, Dinesh JACC Case Rep Case Report Completely leadless cardiac resynchronization therapy is feasible with the combination of Micra AV pacemaker (Medtronic Inc) and WiSE-CRT (EBR Inc) systems. Several reports have highlighted this combination in Europe. This case report presents a 1- year follow-up the first reported concomitant use of the leadless systems in the United States. (Level of Difficulty: Advanced.) Elsevier 2023-09-16 /pmc/articles/PMC10589444/ /pubmed/37869212 http://dx.doi.org/10.1016/j.jaccas.2023.102020 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Mehlhorn, Donald
Patel, Sankalp
Verghese, Dhiran
Azad, Hashem
Sharma, Dinesh
Long-Term Outcome of the First Completely Leadless Cardiac Resynchronization Therapy in the United States
title Long-Term Outcome of the First Completely Leadless Cardiac Resynchronization Therapy in the United States
title_full Long-Term Outcome of the First Completely Leadless Cardiac Resynchronization Therapy in the United States
title_fullStr Long-Term Outcome of the First Completely Leadless Cardiac Resynchronization Therapy in the United States
title_full_unstemmed Long-Term Outcome of the First Completely Leadless Cardiac Resynchronization Therapy in the United States
title_short Long-Term Outcome of the First Completely Leadless Cardiac Resynchronization Therapy in the United States
title_sort long-term outcome of the first completely leadless cardiac resynchronization therapy in the united states
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589444/
https://www.ncbi.nlm.nih.gov/pubmed/37869212
http://dx.doi.org/10.1016/j.jaccas.2023.102020
work_keys_str_mv AT mehlhorndonald longtermoutcomeofthefirstcompletelyleadlesscardiacresynchronizationtherapyintheunitedstates
AT patelsankalp longtermoutcomeofthefirstcompletelyleadlesscardiacresynchronizationtherapyintheunitedstates
AT verghesedhiran longtermoutcomeofthefirstcompletelyleadlesscardiacresynchronizationtherapyintheunitedstates
AT azadhashem longtermoutcomeofthefirstcompletelyleadlesscardiacresynchronizationtherapyintheunitedstates
AT sharmadinesh longtermoutcomeofthefirstcompletelyleadlesscardiacresynchronizationtherapyintheunitedstates